Precipio, Inc. Common Stock

PRPONASDAQUSD
23.49 USD
0.13 (0.56%)AT CLOSE (11:59 AM EDT)
21.19
2.30 (9.79%)
POST MARKET (AS OF 07:01 PM EDT)
Post Market
AS OF 07:01 PM EDT
21.19
2.30 (9.79%)
🔴Market: CLOSED
Open?$23.49
High?$23.93
Low?$22.87
Prev. Close?$23.36
Volume?22.9K
Avg. Volume?38.3K
VWAP?$23.48
Rel. Volume?0.60x
Bid / Ask
Bid?$8.86 × 100
Ask?$27.93 × 100
Spread?$19.07
Midpoint?$18.40
Valuation & Ratios
Market Cap?42.0M
Shares Out?1.8M
Float?1.4M
Float %?78.0%
P/E Ratio?N/A
P/B Ratio?2.96
EPS?-$0.52
Dividend?0.00%
Ex-Dividend?N/A

Shares of Precipio, Inc. Common Stock (PRPO) are trading at $23.49. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, PRPO appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Employees
71
Market Cap
42.0M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
2000-07-18
Address
4 SCIENCE PARK
NEW HAVEN, CT 06511
Phone: 203 787 7888
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
75
Short Sent.?
60
Piotroski F-Score?2/9Weak
Altman Z-Score?-2.11Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.07%Low
Short Interest?14.6K
Days to Cover?1.0
Free Float1.4M
Avg Daily Volume33.1K
Settlement Date2026-05-15
Financial Health
Current Ratio?1.56Adequate
Quick Ratio?1.33Adequate
Cash Ratio?0.68Adequate
Debt/Equity?0.07Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
87/100
P/E?
N/A
P/B?
Peers
100
S&P
56
2.96CHEAP
P/S?
Peers
100
S&P
76
1.60CHEAP
P/FCF?
Peers
100
S&P
3
75.7PRICEY
EV/EBITDA?
S&P
97
-66.7CHEAP
EV/Sales?
Peers
100
S&P
83
1.53CHEAP
Returns & Efficiency
ROE?
S&P
10
-6.5%WEAK
ROA?
S&P
3
-4.4%WEAK
Cash Flow & Enterprise
FCF?$555.0K
Enterprise Value?$40.4M
Fundamentals ratios updated end of day